newsfilter
← Latest News
GlobeNewswire·

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

TUCSON, Ariz., June 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced the customer publication